NatuRem Bioscience ApS: Financial statements 2023
CVR: 39826275
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
NatuRem Bioscience ApS (CVR 39826275) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 394,529 and a net result of DKK 319,530 compared with DKK -24,879 the year before. Equity in the 2023 report amounted to DKK 318,387. The solvency ratio was 79.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 394,529
- Profit/Loss
- DKK 319,530
- Equity
- DKK 318,387
- Total Assets
- DKK 401,014
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 395 t. | 320 t. | 318 t. | 1 |
| 2022 | - | -25 t. | -25 t. | -1 t. | 1 |
| 2021 | - | -6 t. | -6 t. | 24 t. | 1 |
| 2020 | - | -3 t. | -3 t. | 30 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
NatuRem Bioscience ApS has published its annual report for 2022. Gross profit came to DKK -24,862, and the net result was DKK -24,879.
About NatuRem Bioscience ApS
NatuRem Bioscience ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Christopher Kjølby Jensen and Christian Kjølby. The company is owned by Christian Kjølby and Christopher Kjølby Jensen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 555,249 and a net result of DKK 5,040 compared with DKK -41,444 the year before. Equity in the 2025 report amounted to DKK 281,983.